Back to PO PointState Capital LP

ROIVROIV

Showing 6 of 8 quarters

Position history for POPointState Capital LP's holdings in Roivant Sciences Ltd.

No. PointState Capital exited its ROIV (Roivant Sciences) position in Q4 2025. Its Q3 2025 13F listed 1,791,440 shares worth $27.1M. PointState Capital first reported ROIV in Q1 2024 and held it in 7 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$47.4M

Total Shares Change

-4.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$21.70
0
2025-Q3
Decreased
1.8M
-26.2%
$27.1M0.4%$15.13
0
2025-Q2
Decreased
2.4M
-10.6%
$27.3M0.4%$11.27
0
2025-Q1
Decreased
2.7M
-17.7%
$27.4M0.4%$10.09
0
2024-Q4
Decreased
3.3M
-19.7%
$39M0.7%$11.83
0
2024-Q3
Decreased
4.1M
-8.4%
$47.4M0.9%$11.54
0

Optional analytics helps us improve. How it’s used